P-049 - PHARMACOKINETICS AND PHARMACODYNAMICS OF CASIRIVIMAB AND IMDEVIMAB IN A DOSE-RANGING STUDY IN OUTPATIENTS WITH COVID-19.

J. Davis, K. Turner, S. Ganguly, H. Hassan, S. Irvin, M. Partridge, J. Nguyen, K. Lin, C. Portal-Celhay, E. Forleo-Neto, A. Hooper, N. Al-Huniti, H. Yan, A. DiCioccio; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.